Insulin (Lantus)

Insulin glargine differs from endogenous human insulin through specific amino acid modifications that alter its solubility characteristics. After subcutaneous administration, the acidic solution is neutralized in the tissue, leading to the formation of microprecipitates that gradually release insulin glargine over time.

These pharmacokinetic properties have made insulin glargine an important subject of research in endocrinology, diabetes management, and long-acting insulin therapy development. Ongoing research focuses on insulin glargine’s long-term biological effects, signalling behaviour, and role in endocrinology, metabolism, and diabetes-related research models.

Research applications include:

• Insulin receptor signalling studies
• Glucose metabolism research
• Endocrine system investigations
• Glycemic regulation pathway analysis
• Diabetes and metabolic disease research
• Cellular energy homeostasis studies